|
TRRAP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.28019999999729E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.257600E-03 |
| Normal-vs-Stage2 |
8.100400E-02 |
| Normal-vs-Stage3 |
3.781000E-01 |
| Normal-vs-Stage4 |
2.190600E-01 |
| Stage1-vs-Stage2 |
8.134200E-01 |
| Stage1-vs-Stage3 |
3.374800E-01 |
| Stage1-vs-Stage4 |
1.422130E-02 |
| Stage2-vs-Stage3 |
3.413200E-01 |
| Stage2-vs-Stage4 |
7.419500E-02 |
| Stage3-vs-Stage4 |
2.370600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.996000E-04 |
| Normal-vs-AfricanAmerican |
7.276400E-02 |
| Normal-vs-Asian |
3.715400E-01 |
| Caucasian-vs-AfricanAmerican |
2.570400E-01 |
| Caucasian-vs-Asian |
2.560600E-01 |
| AfricanAmerican-vs-Asian |
2.786400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.179300E-04 |
| Normal-vs-Female |
1.144500E-03 |
| Male-vs-Female |
3.422600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.327600E-01 |
| Normal-vs-Extreme_Weight |
4.495700E-02 |
| Normal-vs-Obese |
6.803100E-04 |
| Normal-vs-Extreme_Obese |
5.757200E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.147000E-01 |
| Normal_Weight-vs-Obese |
7.918000E-02 |
| Normal_Weight-vs-Extreme_Obese |
9.825800E-01 |
| Extreme_Weight-vs-Obese |
3.710600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.018800E-01 |
| Obese-vs-Extreme_Obese |
3.066200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.506300E-02 |
| Normal-vs-Age(41-60Yrs) |
6.27399999999501E-05 |
| Normal-vs-Age(61-80Yrs) |
3.610100E-02 |
| Normal-vs-Age(81-100Yrs) |
7.117000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.576000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.256400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.129600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.596000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.451800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.177800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.37089999965967E-07 |
| Normal-VS-Type2 PRCC |
5.546400E-01 |
| Normal-VS-KIRP CIMP |
4.560800E-01 |
| Normal-VS-Unclassified PRCC |
1.301950E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.11679999995162E-06 |
| Type1 PRCC-VS-KIRP CIMP |
2.986000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.917000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.529400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.139500E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
4.076600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.384200E-01 |
| Normal-vs-N1 |
3.881400E-01 |
| Normal-vs-N2 |
3.217200E-01 |
| N0-vs-N1 |
3.793400E-01 |
| N0-vs-N2 |
5.713400E-01 |
| N1-vs-N2 |
9.153000E-01 |
|
|
